Curis INC (CRIS) — 10-K Filings
All 10-K filings from Curis INC. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
CURIS Nears Cash Crunch, Eyes Emavusertib for Accelerated Approval
— Mar 24, 2026 Risk: high
CURIS INC, a biotechnology company, reported a cash and cash equivalents balance of $5.1 million as of December 31, 2025. The company completed a private placem -
Curis, Inc. Files 2023 Annual Report on Form 10-K
— Feb 8, 2024 Risk: medium
CURIS INC (CRIS) filed a Annual Report (10-K) with the SEC on February 8, 2024. Curis, Inc. filed its 2023 Form 10-K on February 8, 2024, reporting on the fisca
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX